Meeting
2011 ASCO Annual Meeting
A pilot study of endogenous heat shock protein vaccines for metastatic melanoma.
Authors
J. M. Heun
Mayo Clinic, Rochester, MN
J. M. Heun , W. K. Nevala , J. B. Allred , V. Suman , M. R. Callstrom , T. D. Atwell , M. A. Farrell , E. Galanis , L. A. Erickson , W. J. Charboneau , S. Markovic
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Melanoma
Clinical Trial Registration Number
NCT00568763
Citation
J Clin Oncol 29: 2011 (suppl; abstr 8593)
Abstract #
8593
Poster Bd #
34F
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
A toll-like receptor agonist to drive melanoma regression as a vaccination adjuvant or by direct tumor application.
First Author: Richard Eldon Royal
Poster
2012 Gastrointestinal Cancers Symposium
Phase Ib study of ipilimumab alone or in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene (vaccine) in pancreatic cancer.
First Author: Dung Thi Le
Poster
2023 ASCO Annual Meeting
Final results: Dose escalation study of a personalized peptide-based neoantigen vaccine in patients with metastatic melanoma.
First Author: Sofie Kirial Mørk
Poster
2023 ASCO Annual Meeting
The validity of a machine learning algorithm in predicting response to immune checkpoint inhibitors in melanoma.
First Author: Faisal Fa'ak